GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Return-on-Tangible-Asset

Lexagene Holdings (Lexagene Holdings) Return-on-Tangible-Asset : -176.35% (As of Nov. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Lexagene Holdings's annualized Net Income for the quarter that ended in Nov. 2022 was $-6.71 Mil. Lexagene Holdings's average total tangible assets for the quarter that ended in Nov. 2022 was $3.81 Mil. Therefore, Lexagene Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Nov. 2022 was -176.35%.

The historical rank and industry rank for Lexagene Holdings's Return-on-Tangible-Asset or its related term are showing as below:

LXXGQ's Return-on-Tangible-Asset is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -2.605
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Lexagene Holdings Return-on-Tangible-Asset Historical Data

The historical data trend for Lexagene Holdings's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Return-on-Tangible-Asset Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -173.19 -315.73 -198.78 -103.82 -99.80

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -161.78 -137.24 -118.62 -162.22 -176.35

Competitive Comparison of Lexagene Holdings's Return-on-Tangible-Asset

For the Medical Devices subindustry, Lexagene Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Return-on-Tangible-Asset falls into.



Lexagene Holdings Return-on-Tangible-Asset Calculation

Lexagene Holdings's annualized Return-on-Tangible-Asset for the fiscal year that ended in Feb. 2022 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Feb. 2022 )  (A: Feb. 2021 )(A: Feb. 2022 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Feb. 2022 )  (A: Feb. 2021 )(A: Feb. 2022 )
=-10.62/( (13.133+8.15)/ 2 )
=-10.62/10.6415
=-99.80 %

Lexagene Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Nov. 2022 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Nov. 2022 )  (Q: Aug. 2022 )(Q: Nov. 2022 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Nov. 2022 )  (Q: Aug. 2022 )(Q: Nov. 2022 )
=-6.712/( (4.156+3.456)/ 2 )
=-6.712/3.806
=-176.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Nov. 2022) net income data.


Lexagene Holdings  (OTCPK:LXXGQ) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Lexagene Holdings Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (Lexagene Holdings) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (Lexagene Holdings) Headlines